Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reexamination Certificate
2007-04-10
2007-04-10
Richter, Johann R. (Department: 1616)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
C514S282000, C514S242000, C514S333000, C514S277000, C514S766000, C514S214030, C514S740000, C514S747000, C514S764000
Reexamination Certificate
active
10723654
ABSTRACT:
This invention relates to an abuse deterrent dosage form of opioid analgesics, wherein an analgesically effective amount of opioid analgesic is combined with a polymer to form a matrix.
REFERENCES:
patent: 3065143 (1962-11-01), Christenson et al.
patent: 3260646 (1966-07-01), Paulsen et al.
patent: 4070494 (1978-01-01), Hoffmeister et al.
patent: 4175119 (1979-11-01), Porter
patent: 4389393 (1983-06-01), Schor et al.
patent: 4457933 (1984-07-01), Gordon et al.
patent: 4459278 (1984-07-01), Porter
patent: 4599342 (1986-07-01), LaHann
patent: 4610870 (1986-09-01), Jain et al.
patent: 4666705 (1987-05-01), DeCrosta et al.
patent: 5059600 (1991-10-01), Gawin et al.
patent: 5114942 (1992-05-01), Gawin et al.
patent: 5330766 (1994-07-01), Morella et al.
patent: 5741524 (1998-04-01), Staniforth et al.
patent: 5968551 (1999-10-01), Oshlack et al.
patent: 6153621 (2000-11-01), Hamann
patent: 6228863 (2001-05-01), Palermo et al.
patent: 6309668 (2001-10-01), Bastin et al.
patent: 6352721 (2002-03-01), Faour
patent: 6375957 (2002-04-01), Kaiko et al.
patent: 6491949 (2002-12-01), Faour et al.
patent: 6559159 (2003-05-01), Carroll et al.
patent: 6572885 (2003-06-01), Oshlack et al.
patent: 6593367 (2003-07-01), Dewey et al.
patent: 2003/0004177 (2003-01-01), Kao et al.
patent: 2003/0064099 (2003-04-01), Oshlack et al.
patent: 2003/0064122 (2003-04-01), Goldberg et al.
patent: 2003/0068276 (2003-04-01), Hughes et al.
patent: 2003/0068370 (2003-04-01), Sackler
patent: 2003/0068375 (2003-04-01), Wright et al.
patent: 2003/0068392 (2003-04-01), Sackler et al.
patent: 2003/0124061 (2003-07-01), Roberts
patent: 2003/0124185 (2003-07-01), Oshlack et al.
patent: 2003/0125347 (2003-07-01), Anderson et al.
patent: 2003/0170181 (2003-09-01), Midha
patent: 2003/0232081 (2003-12-01), Doshi et al.
patent: 2004/0131552 (2004-07-01), Boehm
patent: 2004/0151791 (2004-08-01), Mayo-Alvarez
patent: 2004/0228802 (2004-11-01), Chang et al.
patent: 2005/0020613 (2005-01-01), Boehm et al.
patent: 2005/0063909 (2005-03-01), Wright et al.
patent: 2005/0106249 (2005-05-01), Hwang et al.
patent: 2006/0018837 (2006-01-01), Preston et al.
patent: WO 2003/026743 (2003-04-01), None
patent: WO 2004/026256 (2004-01-01), None
patent: WO 2004/026283 (2004-04-01), None
patent: WO 2004/037259 (2004-05-01), None
Wells, Mickey L. and, Eugene L. Parrott. “Effect of Anionic Surfactants on the Release of Chlorpheniramine Maleate From an Inert, Heterogeneous Matrix.”Drug Development and Industrial Pharmacy18(2) (1992): 175-186.
Rao, B. Sreenivasa and K.V. Ramana Murthy. “Effect of Sodium Lauryl Sulfate on the Release of Rifampicin from Guar Gum Matrix.”Indian Journal of Pharmaceutical Science(2000): 404-406.
Matschiner et al., “Characterization of Ion Pair Formation Between Erythromycin and Lipophilic Counter Ions.”Pharmazie50 (1995): 462-464.
Dixon David
Kumar Vijai
Tewari Divya
Wadgaonkar Dilip B.
Acura Pharmaceuticals, Inc.
Alstrum-Acevedo James H.
Morgan & Lewis & Bockius, LLP
Richter Johann R.
LandOfFree
Methods and compositions for deterring abuse of opioid... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for deterring abuse of opioid..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for deterring abuse of opioid... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3745099